NDC Pharmacologic Class N0000192702 Anthrax Protective Antigen-directed Antibody Interactions [MoA]
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
|---|---|---|---|---|---|---|
| 49401-103 | Raxibacumab | Raxibacumab | Injection | Intravenous | Human Genome Sciences, Inc. | Human Prescription Drug |
| 69604-204 | Anthim | Obiltoxaximab | Solution | Intravenous | Elusys Therapeutics, Inc. | Human Prescription Drug |
| 71655-103 | Raxibacumab | Raxibacumab | Injection | Intravenous | Emergent Manufacturing Operations Baltimore Llc | Human Prescription Drug |
There are 3 NDC products with the pharmacologic class Anthrax Protective Antigen-directed Antibody Interactions [MoA].
